PubMed 36639800

PubMed ID: 36639800

View on PubMed
Systematic optimization of Cas12a base editors in wheat and maize using the ITER platform.
Authors: Gaillochet Christophe, Peña Fernández Alexandra, Goossens Vera, D'Halluin Katelijn, Drozdzecki Andrzej, Shafie Myriam, Van Duyse Julie, Van Isterdael Gert, Gonzalez Camila, Vermeersch Mattias, De Saeger Jonas, Develtere Ward, Audenaert Dominique, De Vleesschauwer David, Meulewaeter Frank, Jacobs Thomas B
Journal: Genome biology (Genome Biol), Vol.24(1), 2023‑Jan‑13

DOI: 10.1038/s41587-019-0032-3 PMCID: PMC9838060

Abstract
Testing an ever-increasing number of CRISPR components is challenging when developing new genome engineering tools. Plant biotechnology has few high-throughput options to perform iterative design-build-test-learn cycles of gene-editing reagents. To bridge this gap, we develop ITER (Iterative Testing of Editing Reagents) based on 96-well arrayed protoplast transfections and high-content imaging.

We validate ITER in wheat and maize protoplasts using Cas9 cytosine and adenine base editors (ABEs), allowing one optimization cycle - from design to results - within 3 weeks. Given that previous LbCas12a-ABEs have low or no activity in plants, we use ITER to develop an optimized LbCas12a-ABE. We show that sequential improvement of five components - NLS, crRNA, LbCas12a, adenine deaminase, and linker - leads to a remarkable increase in activity from almost undetectable levels to 40% on an extrachromosomal GFP reporter. We confirm the activity of LbCas12a-ABE at endogenous targets in protoplasts and obtain base-edited plants in up to 55% of stable wheat transformants and the edits are transmitted to T1 progeny. We leverage these improvements to develop a highly mutagenic LbCas12a nuclease and a LbCas12a-CBE demonstrating that the optimizations can be broadly applied to the Cas12a toolbox.

Our data show that ITER is a sensitive, versatile, and high-throughput platform that can be harnessed to accelerate the development of genome editing technologies in plants. We use ITER to create an efficient Cas12a-ABE by iteratively testing a large panel of vector components. ITER will likely be useful to create and optimize genome editing reagents in a wide range of plant species.
Publication Types
Journal Article Research Support, Non-U.S. Gov't
Keywords
Base editing CRISPR Cas12a Cas9 High-content imaging Plant biotechnology Protoplasts
Related Articles